Zoletil 50, süstelahuse pulber ja lahusti, koertele ja kassidele
Zoletil 50, süstelahuse pulber ja lahusti, koertele ja kassidele
Authorised
- Tiletamine
- Zolazepam
Product identification
Medicine name:
Zoletil 50, süstelahuse pulber ja lahusti, koertele ja kassidele
Active substance:
- Tiletamine
- Zolazepam
Target species:
-
Dog
-
Cat
Route of administration:
-
Intramuscular use
-
Intravenous use
Product details
Active substance and strength:
-
Tiletamine125.00/milligram(s)1.00Vial
-
Zolazepam125.00/milligram(s)1.00Vial
Pharmaceutical form:
-
Powder and solvent for solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Dog
- Cat
-
Intravenous use
- Dog
- Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN01AX99
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Estonia
Package description:
- Available only in Estonian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- VIRBAC
Responsible authority:
- State Agency Of Medicines
Authorisation number:
- 1407
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 15/08/2023
How useful was this page?:
